Bio Developments

Pic: getty/nordroden

AstraZeneca publishes peer-reviewed COVID-19 vaccine results

By Rachel Arthur

The interim analysis of AZD1222's Phase III trials has been peer-reviewed and published in The Lancet today, demonstrating the vaccine is ‘safe and effective at preventing symptomatic COVID-19 and that it protects against severe disease and hospitalisation’.

The first vaccine was delivered at 6.31am GMT this morning. Pic:getty/gam1983

UK starts COVID-19 vaccinations

By Rachel Arthur

The UK has started the biggest vaccine campaign in its history this morning: with the first COVID-19 vaccine delivered to a 90-year-old grandmother.

Pic:getty/dolgachov

Janssen acquires rights to novel AMD gene therapy

By Rachel Arthur

Janssen Pharmaceuticals, Inc. has acquired the rights to Hemera Biosciences’ investigational gene therapy HMR59: which has been designed to help preserve vision in patients with severe age-related macular degeneration (AMD).

Follow us

Products

View more

Webinars